If there is one attribute to which we attach the utmost importance it is quality. Quality is considered paramount at all locations where we conduct regulated research, development, manufacture, testing and distribution of pharmaceutical products. Our operations are driven by best-in-class technology and processes, abiding by all major stringent regulatory approvals. Our commitment to implementing a robust global quality management system is based on our determination to sustain a culture of operational excellence, meeting and exceeding the expectations of all stakeholders, including patients, customers and regulators. Thus, our passion for quality goes beyond business and statutory requirements. Putting patients first is our motto.
Our Quality Management Team ensures that every product manufactured and distributed by us complies with all accepted good practices and standards of quality, purity, efficacy and safety.
To maintain quality standards, every plant has well defined procedures and systems in place in compliance with the requirements of the Good Manufacturing Practices (GMP )
Bipha has well trained personnel for quality control along with a regulatory affairs department ensuring strict adherence to quality systems and procedures. The teams are guided by a Corporate Quality Unit (CQU). CQU ensures that the latest updates in GMP are being translated into guidelines, standard operating procedures (SOPs) and protocols. The teams ensure that these guidelines are implemented to deliver quality products time after time.
Our unwavering commitment to quality goes beyond ourselves. We insist that our business partners comply with national and international regulatory and business standards which are in alignment with those of our own. Our own quality standards are constantly benchmarked against global best practices. This means that these are constantly upgraded to keep pace with the evolving dynamics of the global environment.
We remain committed to the highest levels of quality and will ensure that all our facilities, offices and legal entities continue to meet the exemplary standards that are expected of a global pharmaceutical company.